Home LiteratureArticle Details
PMID: 10982361 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.

Journal of virology ·Vol. 74 ·No. 19 ·2000-10-00 ·Pages 9144-51

Betts MR, Casazza JP, Patterson BA, Waldrop S, Trigona W, Fu TM, Kern F, Picker LJ, Koup RA

Abstract

Recent studies of human immunodeficiency virus (HIV)-specific CD8(+) T cells have focused on responses to single, usually HLA-A2-restricted epitopes as surrogate measures of the overall response to HIV. However, the assumption that a response to one epitope is representative of the total response is unconfirmed. Here we assess epitope immunodominance and HIV-specific CD8(+) T-cell response complexity using cytokine flow cytometry to examine CD8(+) T-cell responses in 11 HLA-A2(+) HIV(+) individuals. Initial studies demonstrated that only 4 of 11 patients recognized the putative immunodominant HLA-A2-restricted p17 epitope SLYNTVATL, suggesting that the remaining subjects might lack significant HIV-specific CD8(+) T-cell responses. However, five of six SLYNTVATL nonresponders recognized other HIV epitopes, and two of four SLYNTVATL responders had greater responses to HIV peptides restricted by other class I alleles. In several individuals, no HLA-A2-restricted epitopes were recognized, but CD8(+) T-cell responses were detected to epitopes restricted by other HLA class I alleles. These data indicate that an individual's overall CD8(+) T-cell response to HIV is not adequately represented by the response to a single epitope and that individual major histocompatibility complex class I alleles do not predict an immunodominant response restricted by that allele. Accurate quantification of total HIV-specific CD8(+) T-cell responses will require assessment of the response to all possible epitopes.

MeSH Terms
Antigen Presentation CD8-Positive T-Lymphocytes/immunology Cytotoxicity, Immunologic HIV Infections/immunology HIV-1/immunology Haplotypes Histocompatibility Antigens Class I/genetics,immunology Humans
Chemicals
Histocompatibility Antigens Class I
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Betts M R
Department of Internal Medicine, Division of Infectious Diseases, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Casazza J P
Patterson B A
Waldrop S
Trigona W
Fu T M
Kern F
Picker L J
Koup R A
References (29)
29 references, click to expand
  1. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
    Nat Med. 1999 Nov;5(11):1270-6 PMID: 10545993
  2. Protective immunity induced by live attenuated simian immunodeficiency virus.
    Curr Opin Immunol. 1998 Aug;10(4):436-43 PMID: 9722920
  3. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
    J Immunol. 1991 Sep 1;147(5):1512-21 PMID: 1715361
  4. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
    Lancet. 1993 Apr 3;341(8849):860-1 PMID: 8096564
  5. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  6. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  7. Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?
    Immunol Rev. 1998 Aug;164:37-51 PMID: 9795762
  8. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
    J Virol. 1999 Jan;73(1):797-800 PMID: 9847391
  9. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  10. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  11. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.
    Annu Rev Immunol. 1999;17:51-88 PMID: 10358753
  12. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.
    J Virol. 1999 Sep;73(9):7108-16 PMID: 10438796
  13. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.
    J Virol. 1999 Oct;73(10):8179-84 PMID: 10482568
  14. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons.
    AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S77-8 PMID: 7532426
  15. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    J Exp Med. 1995 Apr 1;181(4):1365-72 PMID: 7699324
  16. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.
    J Virol. 1995 Sep;69(9):5838-42 PMID: 7637030
  17. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Nat Med. 1995 Jan;1(1):59-64 PMID: 7584954
  18. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques.
    Nat Med. 1995 Nov;1(11):1167-73 PMID: 7584989
  19. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  20. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    J Virol. 1996 Nov;70(11):7569-79 PMID: 8892876
  21. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    J Immunol. 1996 Dec 15;157(12):5543-54 PMID: 8955205
  22. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    Nat Med. 1997 Feb;3(2):212-7 PMID: 9018241
  23. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 PMID: 9050875
  24. Rapid effector function in CD8+ memory T cells.
    J Exp Med. 1997 Sep 15;186(6):859-65 PMID: 9294140
  25. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  26. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  27. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
    J Clin Invest. 1998 Jun 1;101(11):2559-66 PMID: 9616227
  28. T-cell epitope mapping by flow cytometry.
    Nat Med. 1998 Aug;4(8):975-8 PMID: 9701254
  29. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    J Virol. 1999 Dec;73(12):10191-8 PMID: 10559335
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-10-00
Pages
9144-51
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC102113
Subset
IM
Grants
NIAID NIH HHS · R37 AI035522 · United States
NIAID NIH HHS · AI47603 · United States
NIAID NIH HHS · R01 AI047603 · United States
NIAID NIH HHS · AI35522 · United States
NIAID NIH HHS · R01 AI035522 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com